Skip to main content

User account menu

Show — User account menu Hide — User account menu
  • Log in
Home
Amarin

Amarin Corporation Appoints Dr. Steven Ketchum to Head Research and Development and Announces Inducement Grant Under NASDAQ Rule 5635(c)(4)

Submitted by amarin on Fri, 12/08/2017 - 04:48
Home
  • Read more about Amarin Corporation Appoints Dr. Steven Ketchum to Head Research and Development and Announces Inducement Grant Under NASDAQ Rule 5635(c)(4)

Amarin Announces NDA Submission for AMR101 for the Treatment of Patients With Very High Triglycerides

Submitted by amarin on Fri, 12/08/2017 - 04:48
Home
  • Read more about Amarin Announces NDA Submission for AMR101 for the Treatment of Patients With Very High Triglycerides

Amarin to Ring NASDAQ Closing Bell

Submitted by amarin on Fri, 12/08/2017 - 04:48
Home
  • Read more about Amarin to Ring NASDAQ Closing Bell

Amarin Announces Q3, 2011 Results Conference Call

Submitted by amarin on Fri, 12/08/2017 - 04:48
Home
  • Read more about Amarin Announces Q3, 2011 Results Conference Call

Amarin Reports Third Quarter 2011 Results

Submitted by amarin on Fri, 12/08/2017 - 04:48
Home
  • Read more about Amarin Reports Third Quarter 2011 Results

Amarin to Present at Two Upcoming Investor Conferences

Submitted by amarin on Fri, 12/08/2017 - 04:48
Home
  • Read more about Amarin to Present at Two Upcoming Investor Conferences

Amarin's Phase 3 MARINE and ANCHOR Study Data to be Presented at American Heart Association's Scientific Sessions 2011

Submitted by amarin on Fri, 12/08/2017 - 04:48
Home
  • Read more about Amarin's Phase 3 MARINE and ANCHOR Study Data to be Presented at American Heart Association's Scientific Sessions 2011

Amarin's Phase 3 MARINE Study Results Presented at American Heart Association's Scientific Sessions 2011

Submitted by amarin on Fri, 12/08/2017 - 04:48
Home
  • Read more about Amarin's Phase 3 MARINE Study Results Presented at American Heart Association's Scientific Sessions 2011

Amarin's Phase 3 ANCHOR Study Results Presented at American Heart Association's Scientific Sessions 2011

Submitted by amarin on Fri, 12/08/2017 - 04:48
Home
  • Read more about Amarin's Phase 3 ANCHOR Study Results Presented at American Heart Association's Scientific Sessions 2011

Amarin Added to NASDAQ Biotechnology Index

Submitted by amarin on Fri, 12/08/2017 - 04:48
Home
  • Read more about Amarin Added to NASDAQ Biotechnology Index

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 211
  • Page 212
  • Page 213
  • Page 214
  • Current page 215
  • Page 216
  • Page 217
  • Page 218
  • Page 219
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Search

API search

Title (indexed field):
Title (indexed field):
Title (indexed field): Home

Footer menu

Show — Footer menu Hide — Footer menu
  • Contact
Powered by Drupal